Newsroom
Category
January 11, 2021
Dr. Gabriel de Erausquin, Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was interviewed by UPI‘s Brian Dunleavy regarding an article recently published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association; the article cites decades of scientific evidence suggesting it is very likely that COVID-19 will have long-term effects on the brains and […]
January 11, 2021
Dr. Gabriel de Erausquin, Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was interviewed by Michelle Crouch of AARP regarding an article recently published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association; the article cites decades of scientific evidence suggesting it is very likely that COVID-19 will have long-term effects on the brains […]
January 11, 2021
Dr. Gabriel de Erausquin, Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was interviewed by Jon Hamilton, NPR correspondent, regarding an article recently published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association; the article cites decades of scientific evidence suggesting it is very likely that COVID-19 will have long-term effects on the brains […]
January 8, 2021
Dr. Sudha Seshadri, director of UT Health San Antonio’s Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was a live guest Jan. 8 on Fox San Antonio’s Midday news program. She discussed an article recently published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association; the article cites decades of scientific evidence suggesting it […]
January 8, 2021
Dr. Barbara Taylor, Infectious Diseases, was quoted in this story about the launch of the Novavax vaccine clinical trial at UT Health San Antonio and clinical partner University Health. 500 San Antonians are needed for this two-year COVID-19 vaccine study. Read the story.
January 8, 2021
Dr. Barbara Taylor, Infectious Diseases, was interviewed by Univision TV about the launch of the Novavax vaccine clinical trial at UT Health San Antonio and clinical partner University Health. 500 San Antonians are needed for this two-year COVID-19 vaccine study. Watch the story.